← Eichor
Condition: Stage 1 Hypertension Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Stage 1 Hypertension

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Intravenous ZMA001 in Healthy Subjects
Phase 1 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05967299
Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
Phase 1 · 3 location(s) · Kyowa Kirin Co., Ltd. · NCT06823947
A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473
A Trial of "APL-9796'' in Adults With Pulmonary Hypertension
Phase 2 · 6 location(s) · Apollo Therapeutics Ltd · NCT06846554
Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers
Phase 1 · 1 location(s) · Bichedam Co., Ltd. · NCT07282145
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Phase 2 · 35 location(s) · Merck Sharp & Dohme LLC · NCT05587712
External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial
NA · 6 location(s) · Brain Trauma Foundation · NCT05889650
Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
Phase 1 · 1 location(s) · Pharmosa Biopharm Inc. · NCT06429930
Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project
Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT05989581
VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
Phase 1 · 2 location(s) · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · NCT07254481
Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ
Phase N/A · 1 location(s) · Daewoong Pharmaceutical Co. LTD. · NCT07515599
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Co
Phase 1 · 4 location(s) · Life Biosciences Inc. · NCT07290244
DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
Phase 1/Phase 2 · 5 location(s) · Diagonal Therapeutics, Inc. · NCT07623525
SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
Phase 1 · 1 location(s) · Shenzhen Salubris Pharmaceuticals Co., Ltd. · NCT07051603
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.